We became investment partners wish Fishawack Communications in March 2013 to support the founders’ ambitious international buy and build growth plan. They are a specialist medical communications agency providing a range of outsourced professional services to assist large global pharmaceutical companies in educating the medical sector on pharmaceutical products. The business was founded in 2001 by CEO, Oliver Dennis and CFO, Dominic Miller.
During the period of our investment the revenues and EBITDA doubled as the group became a full-service medical communications agency working on global accounts for large pharmaceutical clients such as GSK, Sanofi and Novartis across UK, Switzerland and USA.
In January 2017 we completed the successful sale of Fishawack to a financial buyer.